Biotech Sector Shows No Signs of Slowing. 3 Stocks That Make the Grade.
1. Biotech stocks are gaining momentum, signaling positive investor sentiment. 2. Incyte's shares surged 25% this year, outperforming the biotech ETF. 3. Breakout above $87 could push Incyte towards $104 by year-end. 4. Technical patterns suggest a strong bullish outlook for the biotech sector. 5. Overall biotech ETF shows positive trends, hinting at continued growth.